Release Date: Jun 2019
CC: PC, MK, PBL, ICS, SBP
Charanjeet Singh, MD
Director of Cytopathology, Florida Hospital, Orlando, FL; Assistant Professor of Pathology, University of Central Florida, Orlando, FL
After completing this course, participants will be able to:
- Delineate the immunohistochemical workup in differential diagnoses of plasma cell neoplasms.
- Highlight the current and new markers in plasma cells flow cytometry, especially minimal residual disease.
- Understand the role of cytogenetic and molecular findings in the prognosis of plasma cell neoplasms.
Who should attend? Practicing Pathologists, Residents, Bench Technologists & Technicians, Cytotechnologists
Plasma cell neoplasms present as space-occupying lesions in bone and adjacent soft tissue. Fine needle aspiration is commonly used to sample these lesions, and hence differential diagnoses with non-hematological neoplasms can be encountered. This webcast course highlights the importance of morphology and a limited immunohistochemical panel to distinguish these lesions. Upon diagnosis of plasma cells, effective patient care relies on their sub-classification at a cytogenetic level to assign appropriate risk categories, and upon treatment, ascertaining the minimal residual disease burden. The course highlights these aspects in patients with the diagnosis of a plasma cell neoplasm.